| Document |
Document Title |
|
WO/2003/083074A9 |
|
|
WO/2009/124113A1 |
A process for the purification of sucralose containing aqueous feed streams is disclosed. The process comprises the step of extracting an aqueous feed stream comprising sucralose and impurities less polar than sucralose, such as tetrachl...
|
|
WO/2009/124116A1 |
A process for the extraction of sucralose from an aqueous solution containing at least sucralose, other chlorinated saccharides, sodium chloride and dimethyl ammonium chloride into an organic solvent for sucralose by contacting said orga...
|
|
WO/2009/118532A1 |
The present invention provides a method for producing sucralose from a feed stream comprising a sucrose-6-acylate in a reaction vehicle, wherein said method comprises: (i) reacting the sucrose-6-acylate with a chlorinating agent in order...
|
|
WO/2009/098400A1 |
The invention relates to a chemical compound of the disaccharide type of the following general formula (A): where, Z = O or S; X1 = azido or NHCOR3 where R3 = 1 -5 c alkyl or aryl, X2 = benzyl, H or sulfonate, X3 = -CH2φ, -CHφ forming ...
|
|
WO/2009/089684A1 |
The invention discloses a process for synthesizing sucralose, which comprises reacting sucrose with acetic anhydride in N-amide solvent in the presence of organic complex alkali metal salt catalyst to form sucrose-6-acetate, then chlorid...
|
|
WO/2009/087676A1 |
The present invention relates to an improved process for the preparation of 2, 3, 6, 3', 4'- Penta-O-acetylsucrose (6-PAS) (V) from sucrose. Formula (V)
|
|
WO/2009/087362A2 |
The present invention provides a method for producing sucralose from a feed stream resulting from the chlorination of a sucrose-6-acylate in a reaction vehicle, said feed stream comprising a sucralose-6-acylate, the reaction vehicle, wat...
|
|
WO/2009/087677A1 |
The present invention relates to an improved process for the preparation of 2, 3, 6, 3', 4'- Penta-O-acetylsucrose 6-PAS), formula (V) and sucralose, formula (I).
|
|
WO/2009/075186A1 |
Disclosed is a method for producing a 4-deoxy-4-fluoro-D-glucose derivative, wherein a D-galactose derivative is reacted with sulfuryl fluoride (SO2F2), trifluoromethanesulfonyl fluoride (CF3SO2F) or perfluorobutanesulfonyl fluoride (C4F...
|
|
WO/2009/059945A2 |
1,2-Dideoxy-1,2-diamino oligosaccharides and polysaccharides as shown in General Formula (1) and derivatives thereof are described, and methods suitable for their preparation in free-base, salt or metal-complexed form. In addition, new u...
|
|
WO/2009/049370A1 |
The invention relates to novel compounds that have utility as inhibitors of heparan sulfate-binding proteins; compositions comprising the compounds, and use of the compounds and compositions thereof for the antiangiogenic, antimetastatic...
|
|
WO/2009/047792A2 |
The invention provides carbohydrate based compounds of formula (I), methods of preparation, and compositions useful for modulating signaling through Toll -like receptors. The methods involve contacting a TLR -express ing cell with a carb...
|
|
WO/2009/044886A1 |
The invention aims to provide a process for producing 1,2,3-tri-O-acetyl-5-deoxyribofuranose by an industrially suitable means. The invention provides a process for the production of 1,2,3-tri-O-acetyl-5-deoxyribofuranse which comprises ...
|
|
WO/2009/036754A1 |
The invention relates to a composition having the general structure (formula), wherein R1 is a hydrophobic group, R2 is hydrogen (H), a cation or an alkyl ester, R3 is hydrogen (H) or a group that can be converted into the hydroxy group ...
|
|
WO/2009/025646A1 |
The invention generally features compositions and methods based on the structure-based design of alpha 1 -3 N-Acetylgalactosaminyltransferase (alpha 3 GaINAc-T) enzymes from alpha l-3galactosyltransferase (a3Gal-T) that can transfer 2'-m...
|
|
WO/2009/015446A2 |
The present invention relates to novel compounds and to their use as a medicament, more in particular for the treatment or prevention of viral infections in mammals. The invention also relates to processes for the preparation of compound...
|
|
WO/2009/014970A1 |
Methods of synthesizing sodium glucose co-transporter 2 inhibitors, as well as compounds useful therein, are disclosed. Particular inhibitors are compounds of formula (I).
|
|
WO/2009/006620A1 |
Provided are methods of producing, and compositions comprising, isolated alpha (2→8) or (2→9) oligosialic acid derivatives bearing a non-reducing end enriched for one or more de-N-acetyl residues and resistant to degradation by exone...
|
|
WO/2009/002769A1 |
The present invention discloses A process for producing a carrageenan composition, comprising the steps of: cleaning kappa carrageenan-containing seaweed in water; treating the cleaned seaweed with an aqueous treatment solution, the aque...
|
|
WO/2009/002299A1 |
The invention provides a method of treating a warm-blooded vertebrate. The vertabrate may be a human being or a lower animal. The treatment method involves administering to the vertebrate in need of such treatment a pharmaceutically effe...
|
|
WO/2009/002817A1 |
The present invention discloses a carrageenan composition comprising: sodium in the range of about 5.410 to about 8.230%, preferably about 6.300 to about 8.230%, and more preferably about 7.380 to about 8.230%; potassium in the range of ...
|
|
WO/2009/002297A1 |
A complex of glucosamine having a purity of at least about 99 wt.% and a maximum halide content of about 0.01 wt.%, and a therapeutic drug having a pKa of less than 7. Preferably, the complex is stabilized by coating it with at least one...
|
|
WO/2009/002727A1 |
Disclosed is a carrageenan composition comprising sodium, potassium, calcium and magnesium Further disclosed are uses for the carageenan composition which include a food, an air freshener, a personal care product, a dentifrice, and a pha...
|
|
WO/2008/157515A1 |
The present invention relates to cloning target nucleic acids using phage packaging mechanisms. Packaging initiation sites may be introduced into the target DNA. Components of a phage packaging system may be combined with the target DNA ...
|
|
WO/2008/142155A2 |
The present invention concerns a method for preparing C-6 phosphorylated D- aldohexoses and C-6 phosphorylated D-aldohexose derivatives, new C-6 phosphorylated D-aldohexoses derivatives and uses thereof. The method comprises incubating p...
|
|
WO/2008/144063A1 |
A method of freeze drying sucralose includes contacting a sucralose solution with a cold surface or a cold fluid to freeze the solution, and evaporating the solvent to dry the sucralose. The sucralose solution may include undissolved cry...
|
|
WO/2008/141240A1 |
The present invention includes compositions and methods of making and using a dietary supplement manufactured from one or more natural polysaccharides previously incubated with a probiotic bacteria in a bioreactor system, wherein the bac...
|
|
WO/2008/131024A1 |
Methods of treating glioblastoma and pancreatic cancer are provided by the administration of a therapeutically effective amount of a iodo-hexose compound to a subject in need thereof. The subject invention includes methods of treating gl...
|
|
WO/2008/130373A2 |
The present invention relates to methodology for polymer grafting by a polysaccharide synthase and, more particularly, polymer grafting using the hyaluronate or chondroitin or heparin/heparosan synthases from Pasteurella, in order to cre...
|
|
WO2008067039A9 |
Colchicine neoglycosides, method for their synthesis and methods for their use are discl
|
|
WO/2008/124729A1 |
The present invention provides a one-pot method of preparing an unprotected α-O-glycolipid. The first step involves contacting a protected α-iodo sugar with a catalyst and a lipid comprising a hydroxy group, under conditions sufficient...
|
|
WO/2008/096928A1 |
A method of producing sucralose is disclosed. The method of producing sucralose comprises the steps of preparing a compound (6, 1', 6'-tri- 0 -tritylsucrosepenta- acetate) by reacting sucrose, which is a starting material, with a trityla...
|
|
WO/2008/093239A1 |
A more efficient method for producing glucosamine from microbial biomass such as, for example, fungal biomass is disclosed. In one embodiment, a method for obtaining glucosamine from fungal biomass includes providing fungal biomass conta...
|
|
WO/2008/091539A1 |
A method of making sucralose includes maintaining a solution of a sucralose-6- acylate in an aqueous solvent at a temperature in a range from -20°C to 20°C and at a pH of at least 12.2 and less than 14.0 for a period of time sufficient...
|
|
WO/2008/087425A1 |
There is provided a method for the production of sucralose from a feed stream resulting from the chlorination of a sucrose-6-acylate in a reaction vehicle, said feed stream comprising a sucralose-6-acylate, the reaction vehicle, and by-p...
|
|
WO/2008/084498A1 |
A process is described in which decolorization of solutions or reaction mixtures containing trichlorogalactosucrose or 6-acetyl trichlorogalactosucrose is achieved described by bubbling ozone. The method can be used at various stages in ...
|
|
WO/2008/084561A1 |
It is intended to provide a Helicobacter pylori growth inhibitor which can be produced very simply in a large amount, contains a compound specifically inhibiting Helicobacter pylori growth, is safe and does not cause a resistant bacteriu...
|
|
WO/2008/072933A1 |
The present invention relates to a peptide nucleic acid (PNA) conjugated with multi-amine linkers, and a method to prepare the same and utilization thereof. More specifically, the method is characterized by conjugating monomers having mu...
|
|
WO/2008/070043A2 |
Methods of recovering a triarylmethyl halide from a sucrose derivatization process include the steps of (a) forming a mixture including 1) a triarylmethylated sucrose derivative including at least one triarylmethyl substituent and at lea...
|
|
WO/2008/059035A2 |
The present invention relates to a novel process for the chemical synthesis of β-(1->6)-linked glucosamine disaccharides of the fomula (1) and (intermediate) compounds relating to the process. According to further aspects the invention ...
|
|
WO/2008/058630A1 |
The invention relates to the compounds of formula (I) and to the physiologically acceptable salts thereof. These compounds are suitable, for example, as hypolipidemics.
|
|
WO/2008/059003A1 |
The present invention is directed to sulphated compounds comprising at least one glycosidic amine group, and polysaccharide, oligosaccharide, peptide and protein derivatives comprising such compounds, and mixtures thereof. The present in...
|
|
WO/2008/058628A1 |
The invention relates to the compounds of formula (I) and to the physiologically acceptable salts thereof. These compounds are suitable, for example, as hypolipidemics.
|
|
WO/2008/058631A1 |
The invention relates to the compounds of formula (I) and to the physiologically acceptable salts thereof. These compounds are suitable, for example, as hypolipidemics.
|
|
WO/2008/045419A1 |
The present process provides an improved method for the preparation of 4- amino-l-((2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-hydroxymethyl-3-
methyl- tetrahydro-furan-2-yl)-lH-pyrimidin-2-one of the formula (IV) which is a potent inhibitor of H...
|
|
WO/2008/045015A1 |
Novel processes for the purification of an imino or amino sugar, such as D-1-deoxygalactonojirimycin (DGJ). Particularly, there are described processes for the purification of multi-kilogram scale sugars using hydrochloric acid.
|
|
WO/2008/035222A2 |
The present invention generally relates to tetrahydropyranyl-derivatized amino acids, their syntheses and their incorporation into peptides and peptidomimetics. The tetrahydropyran moiety constrains the side chain of an amino acid, there...
|
|
WO/2008/029734A1 |
A process for producing a radioactive fluorine labeled compound, including the step (S10) of heating a mixture containing [18F] fluoride ions, a phase-transfer catalyst, potassium ions and water in a reactor vessel to thereby evaporate o...
|
|
WO/2008/026222A2 |
The present invention provides novel 1-trihaloacetimido-2-deoxy-2,2'-difluoro-3,5-di-O-protected ribose intermediates. The compounds are useful in the preparation of 2'-deoxy-2,2'-difluoro-beta nucleosides and more particularly 2'-deoxy-...
|
